A lawyer for the U.S. Chamber of Commerce urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare negotiate prices with pharmaceutical companies for selected costly drugs.
A groundbreaking clause in a new deal between HHS and Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers' list prices.
Plenty of legal precedent already allows Medicare to determine what it will pay for healthcare goods and services, DOJ argued this week in defense of new Medicare drug price negotiations.
The California Department of Pharmacy has placed Sutter Coast Hospital Pharmacy on a three year probation, beginning July 23. The violation of proper sanitary protocols occurred in 2019 and involved compounding practices and procedures.
Moderna Inc. agreed to pay German biotechnology company Immatics NV as much as $1.8 billion in a broad-ranging, multiyear collaboration on developing cancer therapies using messenger RNA and other technologies.